Association of platelet-to-HDL cholesterol ratio with frailty and all-cause mortality.
All-cause mortality
Frailty
NHANES
Observational study
Platelet/high-density lipoprotein cholesterol ratio
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
received:
26
08
2024
accepted:
11
10
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
epublish
Résumé
Frailty often requires intensive care, and the admission outcomes of frail patients are often poor. However, owing to the lack of reliable diagnostic indicators, quickly identifying frailty is challenging. The present study aimed to explore the associations of the platelet/high-density lipoprotein cholesterol ratio (PHR; a novel inflammatory indicator) with frailty and all-cause mortality. The present study analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. Frailty was assessed on the basis of the 49-item Frailty Index. The associations of the PHR with frailty and long-term survival prognosis were explored through weighted logistic regression, weighted restricted cubic spline (RCS), and weighted Cox regression, with adjustments for demographic factors, lifestyle, blood lipids, medication history, and complications. In addition, subgroup and interaction analyses were conducted. Finally, several sensitivity analyses were performed. A total of 15,615 adult participants were included, with 7,928 women (53.63%) and an average age of 60.76 years. After fully adjusting for confounding variables, the prevalence of frailty in the highest PHR quartile group of was significantly greater than that in the lowest quartile group (OR: 1.23, 95% CI: 1.04-1.47; P = 0.02). The RCS showed that the inflection point was 166.7. Before and after the inflection point, the PHR was negatively associated (OR: 0.88, 95% CI: 0.80-0.97, P = 0.01) and positively associated (OR: 1.10, 95% CI: 1.02-1.19, P = 0.01) with frailty, respectively. Subgroup analysis suggested that the association between PHR and frailty was stronger in women than in men. A total of 5,544 frail participants were included in the survival analysis. The RCS revealed that the PHR was associated with the all-cause mortality risk of frail participants in a U-shaped manner, with an inflection point of 240.4. Before and after the inflection point, the PHR decreased (HR: 0.89, 95% CI: 0.81-0.97, P = 0.01) and the all-cause mortality risk increased (HR: 1.08, 95% CI: 1.02-1.14, P = 0.01), respectively. The present study suggests that there is a J-shaped association between PHR and frailty in the adult population of the United States and that the association between the PHR and frailty is stronger in women. In addition, the PHR has a U-shaped relationship with the all-cause mortality risk of frail patients.
Sections du résumé
BACKGROUND
BACKGROUND
Frailty often requires intensive care, and the admission outcomes of frail patients are often poor. However, owing to the lack of reliable diagnostic indicators, quickly identifying frailty is challenging. The present study aimed to explore the associations of the platelet/high-density lipoprotein cholesterol ratio (PHR; a novel inflammatory indicator) with frailty and all-cause mortality.
METHODS
METHODS
The present study analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. Frailty was assessed on the basis of the 49-item Frailty Index. The associations of the PHR with frailty and long-term survival prognosis were explored through weighted logistic regression, weighted restricted cubic spline (RCS), and weighted Cox regression, with adjustments for demographic factors, lifestyle, blood lipids, medication history, and complications. In addition, subgroup and interaction analyses were conducted. Finally, several sensitivity analyses were performed.
RESULTS
RESULTS
A total of 15,615 adult participants were included, with 7,928 women (53.63%) and an average age of 60.76 years. After fully adjusting for confounding variables, the prevalence of frailty in the highest PHR quartile group of was significantly greater than that in the lowest quartile group (OR: 1.23, 95% CI: 1.04-1.47; P = 0.02). The RCS showed that the inflection point was 166.7. Before and after the inflection point, the PHR was negatively associated (OR: 0.88, 95% CI: 0.80-0.97, P = 0.01) and positively associated (OR: 1.10, 95% CI: 1.02-1.19, P = 0.01) with frailty, respectively. Subgroup analysis suggested that the association between PHR and frailty was stronger in women than in men. A total of 5,544 frail participants were included in the survival analysis. The RCS revealed that the PHR was associated with the all-cause mortality risk of frail participants in a U-shaped manner, with an inflection point of 240.4. Before and after the inflection point, the PHR decreased (HR: 0.89, 95% CI: 0.81-0.97, P = 0.01) and the all-cause mortality risk increased (HR: 1.08, 95% CI: 1.02-1.14, P = 0.01), respectively.
CONCLUSION
CONCLUSIONS
The present study suggests that there is a J-shaped association between PHR and frailty in the adult population of the United States and that the association between the PHR and frailty is stronger in women. In addition, the PHR has a U-shaped relationship with the all-cause mortality risk of frail patients.
Identifiants
pubmed: 39443978
doi: 10.1186/s12944-024-02329-0
pii: 10.1186/s12944-024-02329-0
doi:
Substances chimiques
Cholesterol, HDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
344Informations de copyright
© 2024. The Author(s).
Références
Canevelli M, Jackson-Tarlton C, Rockwood K. Frailty for neurologists: perspectives on how frailty influences care planning. Lancet Neurol. 2024.
Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365–75.
doi: 10.1016/S0140-6736(19)31786-6
pubmed: 31609228
Hanlon P, Politis M, Wightman H, Kirkpatrick S, Jones C, Khan M, et al. Frailty and socioeconomic position: a systematic review of observational studies. Ageing Res Rev. 2024;100:102420.
doi: 10.1016/j.arr.2024.102420
pubmed: 39025269
Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–32.
doi: 10.1016/S2468-2667(18)30091-4
pubmed: 29908859
pmcid: 6028743
Welstead M, Jenkins ND, Russ TC, Luciano M, Muniz-Terrera G. A systematic review of Frailty trajectories: their shape and influencing factors. Gerontologist. 2020;61(8):e463–75.
doi: 10.1093/geront/gnaa061
pmcid: 8599181
Zhang H, Liu X, Wang X, Jiang Y. Association of two novel systemic inflammatory biomarkers and frailty based on NHANES 2007–2018. Front Public Health. 2024;12:1377408.
doi: 10.3389/fpubh.2024.1377408
pubmed: 38655524
pmcid: 11036374
Bilgin S, Aktas G, Kahveci G, Atak BM, Kurtkulagi O, Duman TT. Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus? Bratisl Lek Listy. 2021;122(2):116–9.
pubmed: 33502879
Jialal I, Jialal G, Adams-Huet B. The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes Metab Res Rev. 2021;37(6):e3403.
doi: 10.1002/dmrr.3403
pubmed: 32886844
Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol. 2018;6(9):743–52.
doi: 10.1016/S2213-8587(18)30110-4
pubmed: 30017798
Ni J, Lv L, Wu P, Xu C. Associations between the platelet/high-density lipoprotein cholesterol ratio and likelihood of nephrolithiasis: a cross-sectional analysis in United States adults. Front Endocrinol (Lausanne). 2024;15:1289553.
doi: 10.3389/fendo.2024.1289553
pubmed: 38449847
Li X, Cui L, Xu H. Association between systemic inflammation response index and chronic k idney disease: a population-based study. Front Endocrinol.15:1329256.
Lu CF, Cang XM, Liu WS, Wang LH, Huang HY, Sang SM, et al. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020. Lipids Health Dis. 2023;22(1):130.
doi: 10.1186/s12944-023-01861-9
pubmed: 37568178
pmcid: 10422828
Zhang H, Xu Y, Xu Y. The association of the platelet/high-density lipoprotein cholesterol ratio with self-reported stroke and cardiovascular mortality: a population-based observational study. Lipids Health Dis. 2024;23(1):121.
doi: 10.1186/s12944-024-02115-y
pubmed: 38659020
pmcid: 11040779
Huang C, Guan Y, Chen L, Xu Y, Yang H. The association of platelet count, high-density lipoprotein cholesterol, and platelet/high-density lipoprotein cholesterol ratio with serum soluble Klotho. Lipids Health Dis. 2024;23(1):251.
doi: 10.1186/s12944-024-02242-6
pubmed: 39153988
pmcid: 11330610
Veronesi F, Borsari V, Cherubini A, Fini M. Association of Klotho with physical performance and frailty in middle- aged and older adults: a systematic review. Exp Gerontol.154:111518.
Guan Z, Ma L, Wu C. Association between serum Klotho and Physical Frailty in Middle-aged a nd older adults: finding from the National Health and Nutrition Examin ation survey. J Am Med Dir Assoc.24(8):1173–e82.
Jiang Z, Wang J, Cai X, Wang P, Liu S. L-shaped association of serum α-Klotho and frailty among the middle-ag ed and older adults: results from NHANES 2007–2016. BMC Geriatr.23(1):716.
Hakeem FF, Bernabé E, Sabbah W. Association between Oral Health and Frailty among American older adults. J Am Med Dir Assoc. 2021;22(3):559–e632.
doi: 10.1016/j.jamda.2020.07.023
pubmed: 32859517
Joo SH, Song JW, Shin K, Kim MJ, Lee J, Song YW. Knee osteoarthritis with a high grade of Kellgren–Lawrence score is associated with a worse frailty status, KNHANES 2010–2013. Sci Rep. 2023;13(1):19714.
doi: 10.1038/s41598-023-46558-2
pubmed: 37953320
pmcid: 10641064
Zhang X, Ma N, Lin Q, Chen K, Zheng F, Wu J, et al. Body roundness index and all-cause Mortality among US adults. JAMA Netw Open. 2024;7(6):e2415051.
doi: 10.1001/jamanetworkopen.2024.15051
pubmed: 38837158
pmcid: 11154161
Ye C, Chen G, Huang W, Liu Y, He Z, Hu M et al. Association between the platelet/high-density lipoprotein cholesterol ratio and depression: a cross-sectional analysis in United States adul ts. Journal of affective disorders.S0165-327(24)01612-4.
Zhang H, Xu Y, Xu Y. The association of the platelet/high-density lipoprotein cholesterol r atio with self-reported stroke and cardiovascular mortality: a populat ion-based observational study. Lipids Health Dis.23(1):121.
Tang Y, Zhai Y, Song W, Zhu T, Xu Z, Jiang L, et al. Association between complete blood count-derived inflammatory markers and the risk of frailty and mortality in middle-aged and older adults. Front Public Health. 2024;12:1427546.
doi: 10.3389/fpubh.2024.1427546
pubmed: 39145178
pmcid: 11323558
Li X, Cui L, Xu H. Association between systemic inflammation response index and chronic kidney disease: a population-based study. Front Endocrinol (Lausanne). 2024;15:1329256.
doi: 10.3389/fendo.2024.1329256
pubmed: 38455650
Huang C, Guan Y, Chen L, Xu Y, Yang H. The association of platelet count, high-density lipoprotein cholestero l, and platelet/high-density lipoprotein cholesterol ratio with serum soluble Klotho. Lipids Health Dis.23(1):251.
Zhang H, Xu Y, Xu Y. The value of the platelet/high-density lipoprotein cholesterol ratio i n predicting depression and its cardiovascular disease mortality: a Po pulation-based observational study. Front Endocrinol.15:1402336.
Jiang X, Xu X, Ding L, Lu J, Zhu H, Zhao K et al. The association between metabolic syndrome and presence of frailty: a systematic review and meta-analysis. Eur Geriatr Med.13(5):1047–56.
Dao HHH, Burns MJ, Kha R, Chow CK, Nguyen TN. The relationship between metabolic syndrome and Frailty in older Peopl e: a systematic review and Meta-analysis. Geriatr (Basel).7(4):76.
McCarthy K, Laird E, O’Halloran AM, Fallon P, Ortuño RR, Kenny RA. Association between metabolic syndrome and risk of both prevalent and incident frailty in older adults: Findings from The Irish Longitudinal Study on Ageing (TILDA). Experimental gerontology.172:112056.
Stranahan AM. Visceral adiposity, inflammation, and hippocampal function in obesity. Neuropharmacology. 2022;205:108920.
doi: 10.1016/j.neuropharm.2021.108920
pubmed: 34902347
Divella R, Gadaleta Caldarola G, Mazzocca A. Chronic inflammation in obesity and Cancer Cachexia. J Clin Med. 2022;11(8).
Mehta M, Louissaint J, Parikh NS, Long MT, Tapper EB. Cognitive function, Sarcopenia, and inflammation are strongly Associated with Frailty: a Framingham Cohort Study. Am J Med. 2021;134(12):1530–8.
doi: 10.1016/j.amjmed.2021.07.012
pubmed: 34464599
pmcid: 9004665
Luo L, Qin R, Liu T, Yu M, Yang T, Xu G. OsASN1 plays a critical role in asparagine-dependent Rice Development. Int J Mol Sci. 2018;20(1).
Perkisas S, Vandewoude M. Where frailty meets diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):261–7.
doi: 10.1002/dmrr.2743
pubmed: 26453435
Naimimohasses S, O’Gorman P, McCormick E, Ferguson D, Monaghan A, McGrath M et al. Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease. BMJ Open Gastroenterol. 2022;9(1).
Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–22.
doi: 10.1038/s41591-018-0104-9
pubmed: 29967350
pmcid: 6553468
Burton JK, Stewart J, Blair M, Oxley S, Wass A, Taylor-Rowan M et al. Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age Ageing. 2022;51(3).
Hamer M, O’Donovan G, Stamatakis E. High-density lipoprotein cholesterol and mortality: too much of a good thing? Arterioscler Thromb Vasc Biol. 2018;38(3):669–72.
doi: 10.1161/ATVBAHA.117.310587
pubmed: 29326314
Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, et al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous Cardiovascular conditions: the CANHEART Study. J Am Coll Cardiol. 2016;68(19):2073–83.
doi: 10.1016/j.jacc.2016.08.038
pubmed: 27810046
Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478–86.
doi: 10.1093/eurheartj/ehx163
pubmed: 28419274
Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-JAPAN study. J Clin Lipidol. 2018;12(3):674–e845.
doi: 10.1016/j.jacl.2018.01.014
pubmed: 29506864
Hernández B, Fuentes E, Palomo I, Alarcón M. Increased platelet function during frailty. Exp Hematol.77:12–e252.
Hannan M, Chen J, Hsu J, Zhang X, Saunders MR, Brown J, et al. Frailty and Cardiovascular outcomes in adults with CKD: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2024;83(2):208–15.
pubmed: 37741609
Jiang Z, Wang J, Cai X, Wang P, Liu S. L-shaped association of serum α-Klotho and frailty among the middle-aged and older adults: results from NHANES 2007–2016. BMC Geriatr. 2023;23(1):716.
doi: 10.1186/s12877-023-04324-z
pubmed: 37924002
pmcid: 10623765
Chang E, Varghese M, Singer K. Gender and sex differences in adipose tissue. Curr Diab Rep. 2018;18(9):69.
doi: 10.1007/s11892-018-1031-3
pubmed: 30058013
pmcid: 6525964
Nuzzo JL. Sex differences in skeletal muscle fiber types: a meta-analysis. Clin Anat.37(1):81–91.
Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1–8.
doi: 10.1016/j.arr.2016.08.006
pubmed: 27592340
Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade infla mmation. J Endocrinol.222(3):R113–27.
Shin MJ, Jeon YK, Kim IJ. Testosterone and Sarcopenia. World J Mens Health.36(3):192–8.
Critchlow AJ, Hiam D, Williams R, Scott D, Lamon S. The role of estrogen in female skeletal muscle aging: a systematic review. Maturitas. 2023;178:107844.
doi: 10.1016/j.maturitas.2023.107844
pubmed: 37716136
Singh-Manoux A, Shipley MJ, Bell JA, Canonico M, Elbaz A, Kivimäki M. Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality. CMAJ. 2017;189(10):E384–90.
doi: 10.1503/cmaj.160313
pubmed: 27895145
pmcid: 5359103
Xu Y, Sun Z. Molecular basis of Klotho: from gene to function in aging. Endocr Rev.36(2):174–93.